Response to Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced Oral Cancer

Conditions: Oral Cancer Interventions: Drug: PD-1 inhibitor+carboplatin+albumin-bound paclitaxel Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials